CLINICAL_TRIALS
trial_result
· 2021-04-28
Clinical Trial Update: Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial assessing Bexagliflozin as monotherapy in adults with Type 2 Diabetes Mellitus has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theracos | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-04-28